Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.59 -0.02 (-2.88%)
At close: Oct 22, 2026 · 4:00 PM EDT

Rani Therapeutics Holdings (RANI) Receivables - Other (2020 - 2024)

Updated

Rani Therapeutics Holdings (RANI) posted Receivables - Other of $428,000 for Q4 2024.

Analysis

Rani Therapeutics Holdings (RANI) Receivables - Other (2020 - 2024) Analysis & Trends

  • Annual Receivables - Other shows a four-year compound annual growth rate of -29.4% (FY2020 to FY2024).
  • In prior years, Rani Therapeutics Holdings' Receivables - Other was $1.72 million in FY2020.
  • The Q4 2024 figure stands as the highest quarterly Receivables - Other since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Rani Therapeutics Holdings 109.55 Mn -10.01 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 428,000.00
Dec 31, 2020 1.72 Mn
API Access

Rani Therapeutics Holdings Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=RANI&period=max&api_key=YOUR_API_KEY